[1] Marchand F, Raskin A, Dionnes-Hornes A, et al.Dental implants and diabetes: conditions for success[J]. Diabetes Metab, 2012, 38(1): 14-19. [2] Wu YY, Xiao E, Graves DT.Diabetes mellitus related bone metabolism and periodontal disease[J]. Int J Oral Sci, 2015, 7(2): 63-72. [3] Khan TS, Fraser LA.Type 1 diabetes and osteoporosis: from molecular pathways to bone phenotype[J]. J Osteoporos, 2015, 2015: 174186. [4] Kitaori T, Ito H, Schwarz EM, et al.Stromal cell-derived factor1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model[J]. Arthritis Rheum, 2009, 60(3): 813-823. [5] Nevins M, Giannobile WV, McGuire MK, et al. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial[J]. J Periodontol, 2005, 76(12): 2205-2215. [6] Zhao Y, Zhang S, Zeng D, et al.rhPDGF-BB promotes proliferation and osteogenic differentiation of bone marrow stromal cells from streptozotocin-induced diabetic rats through ERK pathway[J]. Biomed Res Int, 2014, 2014: 637415. [7] Cui Y, Sun YW, Lin HS, et al.Platelet-derived growth factor-BB induces matrix metalloproteinase-2 expression and rat vascular smooth muscle cell migration via ROCK and ERK/p38 MAPK pathways[J]. Mol Cell Biochem, 2014, 393(1-2): 255-263. [8] Donovan J, Abraham D, Norman J.Platelet-derived growth factor signaling in mesenchymal cells[J]. Front Biosci (Landmark Ed), 2013, 18: 106-119. [9] Casati L, Celotti F, Negri-Cesi P, et al.Platelet derived growth factor (PDGF) contained in platelet rich plasma (PRP) stimulates migration of osteoblasts by reorganizing actin cytoskeleton[J]. Cell Adh Migr, 2014, 8(6): 595-602. [10] Yu L, Tu Q, Han Q, et al.Adiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway: an approach for treating bone disease in diabetes[J]. Stem Cells, 2015, 33(1): 240-252. [11] 杨志峰, 杨清玲, 陈昌杰. 趋化因子SDF-1与受体CXCR4的研究进展[J]. 分子诊断与治疗杂志, 2011, 3(1): 58-61. [12] Tyndall WA, Beam HA, Zarro C, et al.Decreased platelet derived growth factor expression during fracture healing in diabetic animals[J]. Clin Orthop Relat Res, 2003, (408): 319-330. [13] Xu L, Zhang W, Lv K, et al.Peri-implant bone regeneration using rhPDGF-BB, BMSCs, and beta-TCP in a canine model[J]. Clin Implant Dent Relat Res, 2015, 18(2): 241-252. [14] Zhang Y, Ma Y, Wu C, et al.Platelet-derived growth factor BB gene-released scaffolds: biosynthesis and characterization[J]. J Tissue Eng Regen Med, 2013, 10(10): E372-E381. [15] Nedeau AE, Bauer RJ, Gallagher K, et al.A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells[J]. Exp Cell Res, 2008, 314(11-12): 2176-2186. [16] Yoshida S, Iwasaki R, Kawana H, et al.PDGFBB promotesPDGFRalpha-positive cell migration into artificial bone in vivo[J]. Biochem Biophys Res Commun, 2012, 421(4): 785-789. [17] Tokunaga A, Oya T, Ishii Y, et al.PDGF receptor beta is a potent regulator of mesenchymal stromal cell function[J]. J Bone Miner Res, 2008, 23(9): 1519-1528. [18] Kucia M, Jankowski K, Reca R, et al.CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion[J]. J Mol Histol, 2004, 35(3): 233-245. [19] Zhang B, Liu N, Shi H, et al.High glucose microenvironments inhibit the proliferation and migration of bone mesenchymal stem cells by activating GSK3beta[J]. J Bone Minerl Metab, 2016, 34(2): 140-150. [20] Jiang Y, Jahagirdar BN, Reinhardt RL, et al.Pluripotency of mesenchymal stem cells derived from adult marrow[J]. Nature, 2002, 418(6893): 41-49. |